ARCHIVES

Preventive Ovarian Surgery Recommended For Women with BRCA1 Mutations by Age 35

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Pilot to Speed Phase III Trials Deemed Unsuccessful, Will Be Shut Down

November 22, 2002

FDA Approves Rituxan For CLL

February 19, 2010

NCAB Committee Close To Definition Of QRA

February 11, 1983

FDA Grants Orphan Designation To Photofrin for Mesothelioma

December 30, 2011

NCI Preparing RFA for Genetics Network; Patients Want Gene-Environment Studies

August 9, 1996

Murray Copeland Display Dedicated

March 18, 1983